Signaling pathways
-
A9078 Z-FY-CHOSummary: Z-FY-CHO is a potent and specific cathepsin L inhibitor. -
A9082 Taurocholic acid-d4Summary: Taurocholic acid-d4 is deuterium labeled Taurocholic acid. It intended for use as an internal standard for the quantification of TCA by GC- or LC-MS. -
A9083 L-Cysteine-¹³C3Summary: L-Cysteine-¹³C3 is the ¹³C-labeled L-Cysteine. It acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans. -
BA5199 ML-18Summary: A nonapeptide belladonna peptide receptor subtype-3 (BRS-3) antagonist that inhibits lung cancer growth. - BA5200 BIM-26226Summary: BIM-26226 is a gastrin-releasing peptide that is a potent and selective antagonist.
- BA5201 BradykininSummary: Bradykinin is a potent endothelium-dependent vasodilator that lowers blood pressure.
- BA5202 SSR240612Summary: SSR240612 is a potent, orally available, specific non-peptide bradykinin B1 receptor antagonist.
- BA5203 LobradimilSummary: Lobradimil (RMP7), a synthetic form of bradykinin (bradykinin) analog, is a potent and selective bradykinin B2 receptor agonist (0.54 nM).
- BA5204 FulimetibantSummary: A bradykinin receptor antagonist.
- BA5205 OLHHASummary: OLHHA is a dual receptor antagonist and agonist.